Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

2.0K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K
What are Viruses?00:50

What are Viruses?

128.4K
Overview
128.4K
What is Genetic Engineering?00:49

What is Genetic Engineering?

80.4K
Overview
80.4K
Heat Engines01:10

Heat Engines

3.7K
A heat engine is a device used to extract heat from a source and then convert it into mechanical work used for various applications. For example, a steam engine on an old-style train can produce the work needed for driving the train.
Whenever we consider heat engines (and associated devices such as refrigerators and heat pumps), we do not use the standard sign convention for heat and work. For convenience, we assume that the symbols Qh, Qc, and W represent only the amounts of heat transferred...
3.7K
Combining Functions01:16

Combining Functions

246
Functions can be combined to form new mathematical models that describe interactions between variables. These combinations are fundamental in understanding relationships between changing quantities and are commonly encountered in scientific and engineering contexts. The combination methods—addition, subtraction, multiplication, division, and composition—each have unique implications for the resulting function’s domain and behavior.When combining functions through arithmetic...
246
Impedance Combination01:21

Impedance Combination

758
Consider a string of christmas lights, each bulb symbolizing an impedance element. In this series configuration, the flow of electric current remains uniform across every component. This behavior aligns with Kirchhoff's Voltage Law (KVL), which asserts that the total impedance in such a setup equals the sum of individual impedances—akin to resistors in series. It follows that the voltage from the power source is distributed proportionally among these components, adhering to the voltage...
758

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

GPNMB-directed CAR T cell therapy against MiT/TFE-family fusion-driven solid tumors.

Nature cancer·2026
Same author

CRI-CCTG-0003/IND.240 an immunotherapy platform study in platinum-resistant high grade serous ovarian cancer (IPROC): Sub-studies A and B: Durvalumab (D) + mecbotamab vedotin (BA3011) or ozuriftamab vedotin (BA3021).

Cancer treatment and research communications·2026
Same author

Rethinking ovarian cancer III: the past decade and future directions.

Nature reviews. Cancer·2026
Same author

Clinicopathologic and molecular predictors of survival in BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Nature communications·2026
Same author

Multidimensional Characterization of Tumor-Immune Architecture Reveals Clinically Relevant Classic Hodgkin Lymphoma Subtypes.

Cancer discovery·2026
Same author

Copper ionophores drive divergent responses to immune checkpoint inhibition across colorectal tumor models.

Cancer letters·2026

Related Experiment Video

Updated: Feb 11, 2026

Growth, Purification, and Titration of Oncolytic Herpes Simplex Virus
06:14

Growth, Purification, and Titration of Oncolytic Herpes Simplex Virus

Published on: May 13, 2021

7.5K

Oncolytic viruses as engineering platforms for combination immunotherapy.

Kwame Twumasi-Boateng1, Jessica L Pettigrew2, Y Y Eunice Kwok1

  • 1Trev and Joyce Deeley Research Centre, British Columbia Cancer Agency, Victoria, British Columbia, Canada.

Nature Reviews. Cancer
|April 27, 2018
PubMed
Summary

Oncolytic viruses (OVs) offer a promising future for cancer immunotherapy by acting as versatile platforms. These engineered viruses can enhance anti-tumor immunity and overcome treatment barriers, leading to more effective cancer therapies.

More Related Videos

Ex Vivo Infection of Live Tissue with Oncolytic Viruses
12:08

Ex Vivo Infection of Live Tissue with Oncolytic Viruses

Published on: June 25, 2011

13.4K
Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats
08:55

Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats

Published on: April 15, 2016

10.0K

Related Experiment Videos

Last Updated: Feb 11, 2026

Growth, Purification, and Titration of Oncolytic Herpes Simplex Virus
06:14

Growth, Purification, and Titration of Oncolytic Herpes Simplex Virus

Published on: May 13, 2021

7.5K
Ex Vivo Infection of Live Tissue with Oncolytic Viruses
12:08

Ex Vivo Infection of Live Tissue with Oncolytic Viruses

Published on: June 25, 2011

13.4K
Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats
08:55

Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats

Published on: April 15, 2016

10.0K

Area of Science:

  • Oncology
  • Immunology
  • Virology

Background:

  • Current immunotherapies like immune checkpoint blockade, adoptive T cell therapy, and cancer vaccines show promise but require combination strategies for broader efficacy.
  • Combinations of anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA4) and anti-programmed cell death protein 1 (PD1) inhibitors improve response rates in some metastatic melanoma patients.
  • Cancer heterogeneity necessitates complex immunomodulatory combinations, posing challenges in toxicity, feasibility, and cost.

Purpose of the Study:

  • To propose oncolytic viruses (OVs) as multiplexed immune-modulating platforms for advanced cancer immunotherapy.
  • To illustrate how OVs can overcome barriers in T cell-mediated tumor destruction.
  • To highlight novel synergistic mechanisms for cancer treatment using engineered OVs.

Main Methods:

  • Conceptual framework presented through an opinion article.
  • Discussion of OV engineering for selective tumor replication and immune augmentation.
  • Analysis of the T cell journey from priming to effector function in the tumor microenvironment.

Main Results:

  • OVs can be engineered to express various immune-modulating factors, including checkpoint inhibitors, tumor antigens, cytokines, and T cell engagers.
  • OVs can overcome critical barriers in T cell activation and function within the tumor bed.
  • Engineered OVs offer a pathway to novel synergistic anti-cancer immune responses.

Conclusions:

  • Oncolytic viruses represent a future direction in cancer immunotherapy, serving as adaptable platforms for complex combination strategies.
  • OVs can enhance the efficacy of existing immunotherapies by augmenting anti-tumor immunity and facilitating T cell-mediated cytotoxicity.
  • The strategic use of OVs holds significant potential for achieving durable therapeutic responses across a wider spectrum of cancers.